Fondo Bibliografico Internacional Marzo 2006
Enfermedad hepática alcohólica, hígado
graso y esteatohepatitis no alcohólica.
Are we overestimating the risks of
NASH? Thomas V, Harish K. Gastroenterology 2006;130:1015-6.
Carta
Is NAFLD an incidentaloma? Tarantino
G. Gastroenterology 2006;130:1014-5.
Carta.
Localization of oxidized phosphatidylcholine
in nonalcoholic fatty liver disease: Impact on disease progression. Ikura
Y, Ohsawa M, Suekane T, Fukushima H, Itabe H, Jomura H, Nishiguchi S, Inoue
T, Naruko T, Ehara S, Kawada N, Arakawa T, Ueda M. Hepatology 2006;43:506-14.
La mieloperoxidasa neutrofílica inducida por el estrés oxidativo
comporta una oxidación de la fosfatidilcolina y en la progresión
de la esteatosis hepática.
Cryptogenic cirrhosis and NAFLD: are
they related? Maheshwari A, Thuluvath PJ. American Journal of Gastroenterology
2006;101:664-8.
Revisión.
Clinical model for distinguishing
nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic
fatty liver disease. Palekar NA, Naus R, Larson SP, Ward J, Harrison SA. Liver
International 2006;26:151-6.
Modelo clínico para distinguir la esteatosis simple de la esteatohepatitis
no alcohólica.
Invasive and non-invasive investigations for non-alcoholic
steatohepatitis (NASH): The need for biochemical markers. Ahmed MH. Scandinavian
Journal of Gastroenterology 2006;41:372.
